Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Robinson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Medical Reference Services Quarterly|July 9, 2016
Starting a Fee-Based Systematic Review ServiceAmy Knehans, Esther Dell, Cynthia Robinson
Physical Therapy|June 29, 2005
Incidence of and risk factors for falls following hip fracture in community-dwelling older adultsAnne Shumway-Cook, Marcia A Ciol, William Gruber, et al.
ACS Applied Materials & Interfaces|June 16, 2017
Research Progress toward the Practical Applications of Lithium-Sulfur BatteriesJoshua Lochala, Dianying Liu, Bingbin Wu, et al.
Cancer Causes & Control : CCC|February 18, 2003
Re: Diagnostic radiation and the risk of multiple myeloma (United States)Cynthia Robinson, John Cardarelli, Henry B Spitz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2015
Accuracy Evaluation of CONTOUR(®)PLUS Compared With Four Blood Glucose Monitoring SystemsNancy Dunne, Maria T Viggiani, Scott Pardo, et al.
The Journal of Infectious Diseases|February 24, 2019
Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, KenyaGaudensia Mutua, Omu Anzala, Kerstin Luhn, et al.
The Journal of Infectious Diseases|September 17, 2020
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 StudyNeil Goldstein, Viki Bockstal, Stephan Bart, et al.
NPJ Vaccines|December 21, 2021
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimenViki Bockstal, Auguste Gaddah, Neil Goldstein, et al.
Human Vaccines & Immunotherapeutics|March 25, 2024
Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trialNeil Goldstein, Chelsea McLean, Auguste Gaddah, et al.
American Journal of Industrial Medicine|July 9, 2008
A cohort mortality study of chemical laboratory workers at Department of Energy Nuclear PlantsTravis Kubale, Shannon Hiratzka, Scott Henn, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Medical Reference Services Quarterly|July 9, 2016
Starting a Fee-Based Systematic Review ServiceAmy Knehans, Esther Dell, Cynthia Robinson
Physical Therapy|June 29, 2005
Incidence of and risk factors for falls following hip fracture in community-dwelling older adultsAnne Shumway-Cook, Marcia A Ciol, William Gruber, et al.
ACS Applied Materials & Interfaces|June 16, 2017
Research Progress toward the Practical Applications of Lithium-Sulfur BatteriesJoshua Lochala, Dianying Liu, Bingbin Wu, et al.
Cancer Causes & Control : CCC|February 18, 2003
Re: Diagnostic radiation and the risk of multiple myeloma (United States)Cynthia Robinson, John Cardarelli, Henry B Spitz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2015
Accuracy Evaluation of CONTOUR(®)PLUS Compared With Four Blood Glucose Monitoring SystemsNancy Dunne, Maria T Viggiani, Scott Pardo, et al.
The Journal of Infectious Diseases|February 24, 2019
Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, KenyaGaudensia Mutua, Omu Anzala, Kerstin Luhn, et al.
The Journal of Infectious Diseases|September 17, 2020
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 StudyNeil Goldstein, Viki Bockstal, Stephan Bart, et al.
NPJ Vaccines|December 21, 2021
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimenViki Bockstal, Auguste Gaddah, Neil Goldstein, et al.
Human Vaccines & Immunotherapeutics|March 25, 2024
Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trialNeil Goldstein, Chelsea McLean, Auguste Gaddah, et al.
American Journal of Industrial Medicine|July 9, 2008
A cohort mortality study of chemical laboratory workers at Department of Energy Nuclear PlantsTravis Kubale, Shannon Hiratzka, Scott Henn, et al.
Pageof 5